Related Experiment Video
Updated: May 24, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
DNA methylation changes in cervical cancers
Qiang Lu1, Dehua Ma, Shuping Zhao
1Department of Obstetrics and Gynecology, Affiliated Hospital of Qingdao University School of Medicine, Qingdao, China.
Abstract:
Cervical carcinoma is one of the major causes of death in women worldwide. It is difficult to foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic drugs, surgery, and radiation; therefore, testing of molecular targeted therapies against this malignancy is highly desirable. Cervical cancer is a multistep process with accumulation of genetic and epigenetic alterations in regulatory genes, leading to activation of oncogenes and inactivation or loss of tumor suppressor genes (TSGs). In the last decade, in addition to genetic alterations, epigenetic inactivation of TSGs by promoter hypermethylation has been recognized as an important and alternative mechanism in tumorigenesis. In cervical cancer, epigenetic alterations can affect the expression of papillomavirus as well as host genes in relation to stages representing the multistep process of carcinogenesis. Here we discuss these epigenetic alterations in cervical cancer focusing on DNA methylation.
Insights
Epigenetic alterations, particularly DNA methylation, play a crucial role in cervical cancer development. Understanding these changes is key to developing targeted therapies for this widespread malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical carcinoma is a leading cause of cancer death in women globally.
- Current treatments (chemotherapy, surgery, radiation) have limited impact on cure rates.
- Molecular targeted therapies are highly desirable for cervical cancer treatment.
Purpose of the Study:
- To discuss epigenetic alterations in cervical cancer.
- To focus on DNA methylation as a key epigenetic mechanism.
- To highlight the role of epigenetic changes in multistep carcinogenesis.
Main Methods:
- Review of existing literature on cervical cancer epigenetics.
- Analysis of genetic and epigenetic alterations in tumor suppressor genes (TSGs).
- Focus on promoter hypermethylation as a mechanism for TSG inactivation.
Main Results:
- Cervical cancer involves genetic and epigenetic alterations, including oncogene activation and TSG inactivation.
- Epigenetic inactivation of TSGs via promoter hypermethylation is a significant tumorigenesis mechanism.
- Epigenetic alterations affect both viral and host gene expression during carcinogenesis.
Conclusions:
- Epigenetic modifications, especially DNA methylation, are critical in cervical cancer progression.
- Targeting epigenetic alterations presents a promising avenue for novel therapeutic strategies.
- Further research into DNA methylation patterns can improve understanding and treatment of cervical cancer.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cellular Adaptation IV: Dysplasia and Metaplasia

